Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers

NCT02431442 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obese

Interventions

DRUG: RM-493
DRUG: Placebo

Sponsor

Rhythm Pharmaceuticals, Inc.